STRATIFIDEN
DEAD

Serial Number

79296821

Owner

STRATIFICARE PTE. LTD.

Attorney

Karin Segall

Filing Date

Jul 2, 2020

Add to watchlist:

No watchlists yet
View on USPTO

STRATIFIDEN Trademark

Serial Number: 79296821

STRATIFIDEN is a trademark filed by STRATIFICARE PTE. LTD. on July 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

STRATIFICARE PTE. LTD.

535 Clementi Road, #08-02

Entity Type: 24

Trademark Details

Filing Date

July 2, 2020

Registration Date

Not Registered

Published for Opposition

April 26, 2022

Goods & Services

Biological preparations for medical purposes, namely, preparations for Dengue prognostication; diagnostic reagents for medical use; monoclonal antibody reagents for medical use; tagged antibodies for medical use, namely, preparations for Dengue prognostication; monoclonal antibodies for medical use, namely, reagents for medical diagnosis purposes; immunological antibodies for medical use, namely, immunoassay for medical diagnosis purposes; proteins for medical use in binding antibodies for diagnostic purposes; proteins for medical use in detecting antibodies, for diagnostic purposes; antigens, namely, a group of proteins that are related to severe Dengue; non-medicated serums for Dengue prognostication; immunoassay reagents for medical use, namely, medical diagnostic assays for testing of body fluids and blood; chemical products for immunoassay use, namely, medical monoclonal antibodies, for use in Dengue prognostication; reagents for medical use; test reagents for medical use; chemical test reagents namely, medical diagnostic reagents for testing of body fluids and blood for Dengue prognostication; laboratory reagents for medical use; test reagents for medical diagnosis; chemical reagents for use in medicine; diagnostic reagents for medicinal use; reagents for use in medical diagnosis

Diagnostic testing apparatus for use in immunoassay procedures for medical purposes; medical diagnostic apparatus for Dengue prognostication; diagnostic testing instruments for use in immunoassay procedure for medical purposes; tools for medical diagnostics, namely, the Dengue prognostic test kit; urological diagnostic devices, namely, the Dengue prognostic test kit; medical diagnostic instruments for the analysis of body fluids and blood for Dengue prognostication; medical diagnostic testing apparatus, namely, medical diagnostic apparatus for Dengue prognostication; apparatus for viewing diagnostic test strips, namely, for Dengue prognostic test kit; clinical chemistry analysers for medical use, namely, apparatus for blood fluids and blood analysis for Dengue prognostication; blood testing apparatus; blood testing equipment, namely, absorbance reader for Dengue prognostic test

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 25, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 2, 2023 FICR
ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Dec 2, 2022 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Dec 2, 2022 ABN4
OPPOSITION TERMINATED NO. 999999
Dec 2, 2022 OP.T
OPPOSITION SUSTAINED NO. 999999
Dec 2, 2022 OP.S
REFUSAL PROCESSED BY IB
Sep 20, 2022 RFNT
OPPOSITION INSTITUTED NO. 999999
Aug 30, 2022 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Aug 25, 2022 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Aug 25, 2022 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
May 24, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 26, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Apr 24, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 17, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 6, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 6, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 6, 2022 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 30, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 30, 2022 OPNR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2022 CNSA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 4, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 4, 2021 GNSL
SUSPENSION LETTER WRITTEN
Sep 4, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2021 TROA
REFUSAL PROCESSED BY IB
Feb 21, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 29, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 28, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 9, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 8, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 5, 2021 MAFR
ASSIGNED TO EXAMINER
Dec 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 23, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 29, 2020 REPR